Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2013 Dec 8;23(3):e207–e214. doi: 10.1016/j.jstrokecerebrovasdis.2013.10.009

Table 2.

Outcome of patients with symptomatic intracerebral hemorrhage

Outcome measure Treated with
Clotting factors
n=19		 No Clotting factors

n=26		 Difference in (means,
medians or proportions),
Odds ratios OR, (95%CI)
mRS, median (IQR) 6 (5–6) 4 (4–6) 0 (0, 1)
mRS 4–6, proportion 19 (100%) 22 (85%) 15 (−14.5, 43.1)
mRS 5–6 (Unadjusted)* OR 9.53 (1.09–83.44)
mRS 5–6 (Adjusted) † OR 5.98 (0.61–58.41)
Death, proportion 9 (47.4%) 9 (34.6%) 12.8 (−16.2, 41.7)
Death (Unadjusted) OR 1.7 (0.507–5.7)
Death (Adjusted) ‡ OR 0.246 (0.005–2.121)
Fibrinogen, final level 369.7.2±133.2 500±107.5 −130.3 (−283.5, 23.0)

mRS, indicates modified Rankin scale

IQR indicates interquartile range

*

near-compete separation limited adjustment for multiple risk factors

†

Adjusted for post-TPA NIHSS

‡

Adjusted for presence of GCS(≥9 versus ≤ 8), initial ICH volume(≥30 versus <30), hydrocephalus, presence of intraventricular hemorrhage and PTT.